Evolution of β-lactams resistance in Gram-negative bacteria in Tunisia

References

• Abbassi MS, Torres C, Achour W, Vinué L, Sáenz Y, Costa D, Bouchami O, Ben Hassen A. (2008). Genetic characterization of CTX-M-15-producing Klebsiella pneumoniae and Escherichia coli strains isolated from stem cell transplant patients in Tunisia. Inter. J. of Antimicrob. Agents, 32, 308–314.
   PubMed Web of Science ®Google Scholar
• Aubert D, Naas T, Héritier C, Poirel L, Nordmann P. (2006). Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of β-lactam resistance genes. J Bacteriol, 188, 6506–6514.
   PubMed Web of Science ®Google Scholar
• Barlow M, Reik RA, Jacobs SD, Medina M, Meyer MP, McGowan JE, Tenover FC. (2008). High Rate of Mobilization for blaCTX-Ms. Emerg Infect Dis, 14, 423–428.
   PubMedGoogle Scholar
• Ben Achour N, Mercuri PS, Ben Moussa M, Galleni M, Belhadj O. (2009a). Characterization of a novel extended-spectrum TEM-type beta-lactamase, TEM-164, in a clinical strain of Klebsiella pneumoniae in Tunisia. Microb Drug Resist, 15, 195–199.
   PubMed Web of Science ®Google Scholar
• Ben Achour N, Mercuri PS, Power P, Belhadj C, Ben Moussa M, Galleni M, Belhadj O. (2009b). First detection of CTX-M-28 in a Tunisian hospital from a cefotaxime resistant Klebsiella pneumoniae strain. Path. Biol, 57, 343–348.
   PubMedGoogle Scholar
• Ben Hassen A, Meddeb M, Ben Chaabane T, Zribi M, Ben Redjeb S. (1994). Characteristics of the antibiotic resistance plasmid in Salmonella typhi isolated in Tunis in 1990. Ann Biol Clin (Paris), 52, 133–136.
   PubMedGoogle Scholar
• Ben Redjeb S, Ben Hassen A, Verdet C, Arlet G, Bouabdallah F, Philippon A. (1999). β-lactamase plasmidique (AmpC) chez un Proteus mirabilis en Tunisie. Med Mal Infect, 29, 415–417.
   Google Scholar
• Ben Slama K, Jouini A, Ben Sallem R, Somalo S, Sáenz Y, Estepa V, Boudabous A, Torres C. (2010). Prevalence of broad-spectrum cephalosporin-resistant Escherichia coli isolates in food samples in Tunisia, and characterization of integrons and antimicrobial resistance mechanisms implicated. Inter J Food Microbiol, 137: 281–286
   PubMed Web of Science ®Google Scholar
• Ben-Hamouda T, Foulon T, Ben-Mahrez K. (2004). Involvement of SHV-12 and SHV-2a encoding plasmids in outbreaks of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Tunisian neonatal ward. Microb Drug Resist, 10, 132–138.
   PubMed Web of Science ®Google Scholar
• Bethel CR, Distler AM, Ruszczycky MW, Carey MP, Carey PR, Hujer AM, Taracila M, Helfand MS, Thomson JM, Kalp M, Anderson VE, Leonard DA, Hujer KM, Abe T, Venkatesan AM, Mansour TS, Bonomo RA. (2008). Inhibition of OXA-1 β-lactamase by penems. Antimicrob Agents Chemother, 52, 3135–3143.
   PubMedGoogle Scholar
• Bidet P, Burghoffer B, Gautier V, Brahimi N, Mariani-Kurkdjian P, El-Ghoneimi A, Bingen E, Arlet G. (2005). In vivo transfer of plasmid encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae. Antimicrob Agents Chemother, 49, 3562–3565.
   PubMed Web of Science ®Google Scholar
• Bonnet R. (2004). Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother, 48, 1–14.
   PubMed Web of Science ®Google Scholar
• Bouallegue OG, Ben Salem Y, Fabre L, Demartin M, Grimont PAD, Mzoughi R, Weill FX. (2005). Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extended-spectrum β-lactamase in a neonatal unit in Sousse, Tunisia. J Clin Microbiol, 34, 1037–1044.
   Google Scholar
• Bourouis A, Dubois V, Coulange L, André C, Bejhadj C, Ben Moussa M, Quentin C, Belhadj O.(2009). First report of CTX-M-9 in a clinical isolate of Enterobacter cloacae in a Tunisian hospital. Path Biol, doi:10.1016/j.patbio.2009.03.008.
   PubMedGoogle Scholar
• Boyd DA, Tyler S, Christianson S, McGeer A, Muller MP, Willey BM, Bryce E, Gardam M, Nordmann P, Mulvey MR. (2004). Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extendedspectrum β-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob. Agents Chemother 48, 3758–3764.
   PubMed Web of Science ®Google Scholar
• Bradford PA, Cherubin CE, Idemyor V, Rasmussen BA, Bush K. (1994). Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate. Antimicrob. Agents Chemother, 38, 761–766.
   PubMedGoogle Scholar
• Bush K, Jacoby GA, Medeiros AA. (1995). A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother, 39, 1211–1233.
   PubMed Web of Science ®Google Scholar
• Bush K, Macalintal C, Rasmussen BA, Lee VJ, Yang Y. (1993). Kinetic interactions of tazobactam with β-lactamases from all major structural classes. Antimicrob Agents Chemother, 37, 851–858.
   PubMed Web of Science ®Google Scholar
• Carrër A, Poirel L, Eraksoy H, Cagatay AA, Badur S, Nordmann P. (2008). Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother, 52, 2950–2954.
   PubMed Web of Science ®Google Scholar
• Castanheira M, Mendes RE, Rhomberg PR, Jones RN. (2008). Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. medical centers: molecular evaluation from the MYSTIC Program (2007). Microb Drug Resist, 14, 211–216.
   PubMedGoogle Scholar
• Chouchani C, Ben Achour N, M’Charek A, Belhadj O. (2007). Cloning and sequencing of the class A β-lactamase gene (blaTEM-15) Located on a chromosomal Tn801 transposon. Diag Microbiol Infect Dis, 58, 459–463.
   PubMedGoogle Scholar
• Chouchani C, Berlemont R, Masmoudi A, Galleni M, Frere J-M, Belhadj O, Ben-Mahrez K. (2006). A Novel extended-spectrum TEM-type β-lactamase (TEM-138) From Salmonella enterica serovar Infantis. Antimicrob Agents Chemother, 50, 3183–3185.
   PubMedGoogle Scholar
• Corvec S, Poirel L, Naas T, Drugeon H, Nordmann P. (2007). Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother, 51, 1530–1533.
   PubMedGoogle Scholar
• Cuzon G, Naas T, Lesenne A, Benhammou M, Nordmann P. (2010). Plasmid-mediated carbapenem-hydrolysing OXA-48 β-lactamase in Klebsiella pneumoniae from Tunisia. Int J Antimicrob Agents, 36, 91–93.
   PubMedGoogle Scholar
• Dahmen S, Bettaieb D, Mansour W, Boujaafar N, Bouallègue O, Arlet G. (2010). Characterization and molecular epidemiology of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae in a Tunisian University Hospital. Microb Drug Resist, 16, 163–70.
   PubMed Web of Science ®Google Scholar
• Dahmen S, Poirel L, Mansour W, Bouallègue O, Nordmann P. (2009). Prevalence of plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from Tunisia. Clin Microbiol Infect, 16, 1019–1023
   PubMedGoogle Scholar
• Datta N, Kontomichalou P. (1965). Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature, 208, 239–241.
   PubMed Web of Science ®Google Scholar
• Doloy A, Verdet C, Gautier V, Decre D, Ronco E, Hammami A, Philippon A, Arlet G. (2006). Genetic environment of acquired blaACC-1 β-Lactamase gene in Enterobacteriaceae isolates. Antimicrob Agents Chemother, 50, 4177–4181.
   PubMed Web of Science ®Google Scholar
• Drawz SM, Bonomo RA. (2010). Three Decades of β-Lactamase inhibitors. Clin Microbiol Rev, 23,160–201.
   PubMed Web of Science ®Google Scholar
• Easton CJ, Knowles JR. (1982). Inhibition of the RTEM β-lactamase from Escherichia coli. Interaction of the enzyme with derivatives of olivanic acid. Biochem, 21, 2857–2862.
   PubMedGoogle Scholar
• Elhani D, Bakir L, Aouni M, Passet V, Arlet G, Brisse S, Weill F-X. (2010). Molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumonia strains in a university hospital in Tunis, Tunisia, 1999–2005. Clin Microbiol Infect, 16, 157–164.
   PubMed Web of Science ®Google Scholar
• Fisher J, Belasco JG, Charnas RL, Khosla S, Knowles JR. (1980). β-Lactamase inactivation by mechanism-based reagents. Philos Trans R Soc Lond B Biol Sci, 289, 309–319.
   PubMed Web of Science ®Google Scholar
• Galleni M, Amicosante G, Frere JM. (1988). A survey of the kinetic parameters of class C β-lactamases. Cephalosporins and other β-lactam compounds. Biochem J, 255, 123–129.
   PubMedGoogle Scholar
• Gavin PJ, Suseno MT, Thomson RB, Gaydos JM, Pierson CL, Halstead DC, Aslanzadeh J, Brecher S, Rotstein C, Brossette SE, Peterson LR. (2006). Clinical correlation of the CLSI susceptibility breakpoint for piperacillin-tazobactam against extended-spectrum-beta-lactamase- producing Escherichia coli and Klebsiella species. Antimicrob Agents Chemother, 50, 2244–2247.
   PubMed Web of Science ®Google Scholar
• Girlich D, Naas T, Nordmann P. (2004). Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa. Antimicrob Agents Chemother, 48, 2043–2048.
   PubMed Web of Science ®Google Scholar
• Govinden U, Mocktar C, Moodley P, Sturm AW, Essack SY. (2007). Geographical evolution of the CTX-M β-lactamase− an update. Afr J Biotechnol, 6, 831–839.
   Google Scholar
• Hammami A, Arlet G, Ben Redjeb S, Grimont F, Ben Hassen A, Rekik A, Philippon A. (1991). Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in Tunisia caused by multiply drug resistant Salmonella wien producing SHV-2 beta-lactamase. Eur J Clin Microbiol Infect Dis, 10, 641–646.
   PubMed Web of Science ®Google Scholar
• Hammami S, Gautier V, Ghozzi1 R, Da Costa A, Ben-Redjeb S, Arlet G. (2010). Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrugresistant Pseudomonas aeruginosa clone from Tunis. Clin Microbiol Infect, 16, 189–193.
   PubMedGoogle Scholar
• Helfand MS, Bethel CR, Hujer AM, Hujer KM, Anderson VE, Bonomo RA. (2003). Understanding resistance to β-lactams and β-lactamase inhibitors in the SHV β-lactamase: lessons from the mutagenesis of SER-130. J Biol Chem, 278, 52724–52729.
   PubMedGoogle Scholar
• Jacobs C, Frere JM, Normark S. (1997). Cytosolic intermediates for cell wall biosynthesis and degradation control inducible β-lactam resistance in gram-negative bacteria. Cell, 88, 823–832.
   PubMed Web of Science ®Google Scholar
• Juan C, Gutierrez O, Oliver A, Ayestaran JI, Borrell N, Perez JL. (2005). Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit setting. Clin Microbiol Infect, 11, 887–892.
   PubMedGoogle Scholar
• Kalai Blagui S, Achour W, Abdeladhim A, Ben Hassen A. (2009). Identification of SHV-type extended spectrum β-lactamase genes in Pseudomonas aeruginosa by PCR-restriction fragment length polymorphism and insertion site restriction-PCR. Path Biol, 57, 420–424.
   PubMedGoogle Scholar
• Kalai-Blagui S, Achour W, Abbassi MS, Bejaoui M, Abdeladhim A, Ben Hassen A. (2007). Nosocomial outbreak of OXA-18-producing Pseudomonas aeruginosa in Tunisia. Clin Microbiol Infect, 13, 794–800.
   PubMedGoogle Scholar
• Ktari S, Arlet A, Verdet C, Jaoua S, Kachrid A, Ben Redjeb S, Mahjoubi-Rhimi F, Hammami A. (2009). Molecular epidemiology and genetic environment of acquired blaACC-1 in Salmonella enteric serotype Livingstone causing a large nosocomial outbreak in Tunisia. Mirob Drug Resist, 15, 279–286.
   PubMedGoogle Scholar
• Ktari S, Arlet G, Mnif B, Gautier V, Mahjoubi F, Ben Jmeaa M, Bouaziz M, Hammami A. (2006). Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-β-lactamase, CTX-M-15 extended-spectrum β-lactamase, and CMY-4 AmpC β-lactamase in a Tunisian University Hospital. Antimicrob Agents Chemother, 50, 4198–4201.
   PubMed Web of Science ®Google Scholar
• Labia R., Analysis of the blatoho gene coding for Toho-2-beta-lactamase. (1999). Antimicrob Agents Chemother, 43, 2576–2577.
   PubMed Web of Science ®Google Scholar
• Laraki N, Franceschini N, Rossolini GM, Santucci P, Meunier C, De Pauw E, Amicosante G, Frere JM, Galleni M. (1999). Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-β-lactamase IMP-1 produced by Escherichia coli. Antimicrob Agents Chemother, 43, 902–906.
   PubMed Web of Science ®Google Scholar
• Lartigue MF, Fortineau N, Nordmann P. (2005). Spread of novel expanded-spectrum β-lactamases in Enterobacteriaceae in a university hospital in the Paris area, France. Clin Microbiol Infect, 11, 588–91.
   PubMedGoogle Scholar
• Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, Rossolini GM.. (1999). Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother, 43, 1584–1590.
   PubMed Web of Science ®Google Scholar
• Lavollay M, Mamlouk K, Frank T, Akpabie A, Burghoffer B, Ben Redjeb S, Bercion R, Gautier V, Arlet G. (2006). Clonal dissemination of a CTX-M-15 β-lactamase-producing Escherichia coli strain in the Paris area, Tunis, and Bangui. Antimicrob Agents Chemother, 50, 2433–2438.
   PubMed Web of Science ®Google Scholar
• Lodise TP, Lomaestro JB, Rodvold KA, Danziger LH, Drusano GL. (2004). Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo simulation. Antimicrob Agents Chemother, 48, 4718–4724.
   PubMed Web of Science ®Google Scholar
• Makanera A, Arlet G, Gautier V, Manai M. (2003). Molecular epidemiology and characterization of plasmid-encoded β-lactamases produced by Tunisian clinical isolates of Salmonella enterica serotype Mbandaka resistant to broad-spectrum cephalosporins. J Clin Microbiol, 41, 2940–2945.
   PubMedGoogle Scholar
• Mamlouk K, Boutiba-Ben Boubaker I, Gautier V, Vimont S, Picard B, Ben Redjeb S, Arlet G. (2006). Emergence and outbreaks of CTX-M β-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains in a Tunisian Hospital. J Clin Microbiol, 44, 4049–4056.
   PubMedGoogle Scholar
• Mansour W, Bouallegue O, Dahmen S, Boujaafar N. (2008a). Characterization of the resistance mechanism to β-lactams in Acinetobacter baumannii strains isolated in the university hospital Sahloul in Tunisia (2005). Path Biol, 56, 116–120
   PubMedGoogle Scholar
• Mansour W, Dahmen S, Poirel L, Charfi K, Bettaieb D, Boujaafar N, Bouallegue O. (2009a). Emergence of SHV-2a Extended-Spectrum β-Lactamases in Clinical Isolates of Pseudomonas aeruginosa in a University Hospital in Tunisia. Microb Drug Resist, 15, 295–301.
   PubMedGoogle Scholar
• Mansour W, Poirel L, Bettaieb D, Bouallegue O, Boujaafar N, Nordmanna P. (2009b). Metallo-β-lactamase–producing Pseudomonas aeruginosa isolates in Tunisia. Diagn Microbiol Infect Dis, 64, 458–461.
   PubMed Web of Science ®Google Scholar
• Mansour W, Poirel L, Bettaieb D, Bouallegue O, Boujaafar N., Nordmann P. (2008b). issemination of OXA-23-producing and carbapenem-resistant Acinetobacter baumannii in a University Hospital in Tunisia. Microb Drug Resist, 14, 289–292.
   PubMed Web of Science ®Google Scholar
• Massova I, Mobashery S. (1998). Kinship and diversification of bacterial penicillin-binding proteins and β-lactamases. Antimicrob Agents Chemother, 42, 1–17.
   PubMed Web of Science ®Google Scholar
• Muang YT, Chang SC, Lauderdale TL, Yang AY, Wang JT. (2007). Molecular epidemiology of carbapenem resistant Pseudomonas aeruginosa carrying metallo-β-lactamase genes in Taiwan. Diagn Microbiol Infect Dis, 59, 211–216.
   PubMedGoogle Scholar
• Mulvey MR, Boyd DA, Baker L, Mykytczuk O, Reis EM, Asensi MD, Rodrigues DP, Ng LK. (2004). Characterization of a Salmonella enterica serovar Agona strain harbouring a class 1 integron containing novel OXA-type β-lactamase (blaOXA-53) and 6′-N-aminoglycoside acetyltransferase genes [aac(6′)-I30]. J Antimicrob Chemother, 54, 354–359.
   PubMedGoogle Scholar
• Papp-Wallace KM, Bethel CR, Distler A, Kasuboski C, Taracila M, Bonomo RA. (2010). Inhibitor resistance in the KPC-2 β-lactamase: a pre-eminent property of this class A β-lactamase. Antimicrob Agents Chemother, 54, 890–897.
   PubMed Web of Science ®Google Scholar
• Philippon A, G Arlet Jacoby, GA. (2002). Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother, 46, 1–11.
   PubMed Web of Science ®Google Scholar
• Pitout JD, Chow BL, Gregson DB, Laupland KB, Elsayed S, Church DL. (2007). Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates. J Clin Microbiol, 45, 294–298.
   PubMedGoogle Scholar
• Pitout JD, Revathi G, Chow BL et al. (2008). Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya. Clin Microbiol Infect, 14, 755–759.
   PubMedGoogle Scholar
• Poirel L, Mansour W, Bouallegue O., Nordmann P. (2008). Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97. Antimicrob Agents Chemother, 52, 1613–1617
   PubMedGoogle Scholar
• Poirel L, Nordmann P. (2006). Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect, 12, 826–836.
   PubMed Web of Science ®Google Scholar
• Rhimi-Mahjoubi F, Bernier M, Arlet G, Ben Jemaa Z, Jouve P, Hammami A, Philippon A. (2002). Mise en évidence de la céphalosporinase plasmidique ACC-1 dans différentes entérobactéries (Klebsiella pneumoniae, Proteus mirabilis, Salmonella) isolées dans un hôpital Tunisien (Sfax 1997–2000). Pathol Biol, 50, 7–11.
   PubMed Web of Science ®Google Scholar
• Segal H, Garny S, Elisha BG. (2005) Is ISAba1 customized for Acinetobacter? FEMS Microbiol Lett, 243, 425–429.
   PubMed Web of Science ®Google Scholar
• Sturenburg E, Kuhn A, Mack D, Laufs R. (2004). A novel extended-spectrum β-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance. J Antimicrob Chemother, 54, 406–409.
   PubMed Web of Science ®Google Scholar
• Tenover FC, Mohammed MJ, Gorton TS, Dembek ZF. (1999). Detection and reporting of organisms producing extended-spectrum β-lactamases: survey of laboratories in Connecticut. J Clin Microbiol, 37, 4065–4070.
   PubMed Web of Science ®Google Scholar
• Verdet C, Arlet G, Ben Redjeb S, Ben Hassen A, Lagrange PH, Philippon A. (1998). Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis. FEMS Microbiol Lett, 169, 235–40.
   PubMedGoogle Scholar
• Verdet C, Benzerara Y, Gautier V, Adam O, Ould-Hocine Z, Arlet G. (2006). Emergence of DHA-1-producing Klebsiella spp. in the Parisian region: genetic organization of the ampC and ampR genes originating from Morganella morganii. Antimicrob Agents Chemother, 50, 607–617.
   PubMed Web of Science ®Google Scholar
• Walsh TR, Toleman MA, Poirel L, Nordmann P. (2005). Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev, 18, 306–325.
   PubMed Web of Science ®Google Scholar
• Walter MW, Felici A, Galleni M, Soto RP, Adlington RM, Baldwin JE, Frere JM, Gololobox M, Schofield CJ. (1996). Trifluoromethyl alcohol and ketone inhibitors of metallo-β-lactamases. Bioorg Med Chem Lett, 6, 2455–2458.
   Web of Science ®Google Scholar
• Walther-Rasmussen J, Hoiby N. (2006). OXA-type carbapenemases. J Antimicrob Chemother, 57, 373–383.
   PubMed Web of Science ®Google Scholar
• Winokur PL, Vonstein DL, Hoffman LJ, Uhlenhopp EK, Doern GV. (2001). Evidence for transfer of CMY-2 AmpC β-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob Agents Chemother, 45, 2716–2722.
   PubMed Web of Science ®Google Scholar